Clinical Trial Update: To Compare Safety and Efficacy of Doripenem Versus Imipenem-Cilastatin in Patients With Ventilator-Associated Pneumonia [Phase 3]

View source ↗

Summary

This Phase 3 study comparing doripenem to imipenem-cilastatin in ventilator-associated pneumonia was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Doribax (doripenem)
• Primaxin (imipenem/cilastatin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Ventilator-Associated Pneumonia | Phase 3 | Status: TERMINATED | Results posted: 2012-07-18